Bharat Parenterals Limited has submitted a regulatory disclosure to BSE Limited pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure intimates the scheduling of an Earnings Conference Call to discuss the company's operational and financial performance for the quarter and half year ended September 30, 2026 (Q2FY27 and H1FY27).
The conference call is scheduled for Friday, October 30, 2026, at 4:00 P.M. Indian Standard Time (IST).
The invitation for the call is organized by PhillipCapital (India) Private Limited. The primary speaker representing Bharat Parenterals Limited will be Mr. Bhahim Desai, who holds the position of Director (Strategy & Investor Relations). The call leaders from PhillipCapital are identified as Mr. Srisurya Kalagarla and Ms. Samruddhi Shinde.
Dial-in information includes a primary number (+91 22 6280 1143 / +91 22 7115 8044) accessible from all networks and countries, and toll-free numbers for the USA (18667462133), UK (08081011573), Singapore (8001012045), and Hong Kong (800964448). Participants are encouraged to pre-register using a provided link to avoid wait times.
The disclosure includes important procedural notes: the proceedings of the call will be recorded, and the list and full details of participants will be shared with the corporate (Bharat Parenterals Limited). Participants are expected to provide true and legitimate details. All necessary disclosures to stock exchanges, including call invite intimation, recording details, and call transcripts, are expected to be complied with by the respective corporate.
The letter was signed and digitally verified by Mr. Sharmin Nareshkumar Soni, Company Secretary & Compliance Officer (ICSI Membership No: A-75694), from Vadodara.